Prestige Scientific is an executive search firm that builds innovative leadership teams in Life Sciences, from Discovery through Commercial. We provide our clients with a performance-based hiring system that identifies leaders with past success meeting similar corporate objectives as their own, while overcoming challenges and adhering to critical timelines.
Since our founding in 2001, our search results have led to the landing of critical rounds of funding, the discovery of unmet medical needs, successful regulatory pathway design, merger and acquisition due diligence, executing successful exit strategy, and building successful commercial teams around a marketed product.
Our understanding of which competencies make the difference in a critical hire’s effectiveness can ensure the right experts are identified, and that talent management efforts achieve the greatest return on investment. Learn more about our search process.
Our Qualifications
Our Leadership
Since 2001, Prestige Scientific’s leaders have built innovative leadership teams in the biotech and pharmaceutical industry, and have fostered relationships built on trust and transparency. Their expertise places them as valuable advisors to their clients and candidates. Meet the rest of our team.
Board composition is no longer a static exercise but a dynamic process that must keep pace with the company’s trajectory. As organizations progress through different stages of growth, the expectations placed on directors expand, requiring a deliberate and forward-looking approach to how boards are structured and refreshed. In the realm of corporate governance, having an
Rapid scientific advancement has made the demand for exceptional leadership in life sciences more urgent than ever. In the life sciences industry, where breakthroughs in biotechnology, pharmaceuticals, and healthcare innovation can quite literally change lives, finding the right leadership is critical, according to a recent report from Stephen Provost, managing director and co-founder at Prestige
Prestige Scientific, an executive search firm serving the pharmaceutical and biotechnology sectors, recently added Jennifer Price as vice president of executive search. “We are thrilled to welcome Jennifer Price to the Prestige Scientific team,” said Stephen Provost, managing director and co-founder at Prestige Scientific. “Jennifer’s leadership, deep functional expertise, and strong relationship-driven mindset make her an exceptional
Prestige Scientific, an executive search firm serving the pharmaceutical and biotechnology sectors, has named Emma Wolf as director of interim search. Ms. Wolf is known for her attentive listening, ability to anticipate needs, and authentic approach to relationship-building. Now leading the SME consultant interim and consulting search function practice at Prestige, she is focused on connecting
Wilmington, NC – Prestige Scientific, an executive search firm building diverse executive and board teams in life sciences, has formally announced the promotion of Vanda Hart to Vice President of Finance and Operations and the addition of Jeff Carleton as Director of Executive Search. Vanda Hart – Promoted to Vice President of Finance & Operations
Milford, MA – Prestige Scientific is excited to announce the successfully completed search for a Chief Technology Officer with our partner, a clinical-stage biotechnology company focused on the development of cell therapies in the immunology space. This critical hire brings over 20 years of CMC experience from a range of leading biopharmaceutical companies. Prior to
Milford, MA – Prestige Scientific is excited to announce the successfully completed search for a Fractional Chief Medical Officer with our partner, a well-funded biotech based in California focused on true precision immunology through data-guided target selection with multi-specific antibodies. This team of experienced drug developers has designed bispecific antibodies with “best” and “first”- in
In the realm of corporate governance, having an effective board of directors is crucial for strategic guidance, accountability, and stakeholder protection. As a biotech company transitions from early-stage discovery to late-stage commercialization, the board must evolve to meet changing needs. Here are some considerations for strategically building and maintaining a diverse and effective board throughout
Wilmington, NC – Prestige Scientific is excited to announce the successfully completed search for a Senior Vice President of Translational Medicine with our partner, a clinical stage biopharmaceutical company developing first-in-class drugs in oncology. This critical hire will have a highly visible role, interacting with internal and external stakeholders and reporting into the CEO. This